Carcinoembryonic antigen (CEA) and hepatic metastasis in colorectal cancer: update on biomarker for clinical and biotechnological approaches
M Campos-da-Paz, JG Dórea… - Recent patents on …, 2018 - ingentaconnect.com
Background: Carcinoembryonic Antigen (CEA) is a recommended prognostic marker in
Colorectal Cancer (CRC) for tumor diagnosis and monitoring response to therapy. High CEA …
Colorectal Cancer (CRC) for tumor diagnosis and monitoring response to therapy. High CEA …
Radioimmunotherapy in oncology: overview of the last decade clinical trials
Simple Summary Monoclonal antibody-bearing radionuclides have been under clinical
investigation over the last two decades for their use in theranostic (diagnostic and …
investigation over the last two decades for their use in theranostic (diagnostic and …
Multivalent ligand: design principle for targeted therapeutic delivery approach
C Chittasupho - Therapeutic delivery, 2012 - Taylor & Francis
Multivalent interactions of biological molecules play an important role in many biochemical
events. A multivalent ligand comprises of multiple copies of ligands conjugated to scaffolds …
events. A multivalent ligand comprises of multiple copies of ligands conjugated to scaffolds …
Carrier systems of radiopharmaceuticals and the application in cancer therapy
T Zhang, H Lei, X Chen, Z Dou, B Yu, W Su… - Cell Death …, 2024 - nature.com
Radiopharmaceuticals play a vital role in cancer therapy. The carrier of
radiopharmaceuticals can precisely locate and guide radionuclides to the target, where …
radiopharmaceuticals can precisely locate and guide radionuclides to the target, where …
General overview of radioimmunotherapy of solid tumors
I Navarro-Teulon, C Lozza, A Pèlegrin, E Vivès… - …, 2013 - Taylor & Francis
Radioimmunotherapy (RIT) represents an attractive tool for the treatment of local and/or
diffuse tumors with radiation. In RIT, cytotoxic radionuclides are delivered by monoclonal …
diffuse tumors with radiation. In RIT, cytotoxic radionuclides are delivered by monoclonal …
[HTML][HTML] Radioimmunotheragnosis in Cancer Research
G Garaulet, BB Báez, G Medrano, M Rivas-Sánchez… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary ImmunoPET involves tagging an antibody (a protein that targets cancer
cells) with a radioactive substance that can be seen by imaging. This could non-invasively …
cells) with a radioactive substance that can be seen by imaging. This could non-invasively …
[PDF][PDF] Immunoscintigraphy and radioimmunotherapy in cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013)
Y Peña, A Perera, JF Batista - MEDICC review, 2014 - SciELO Public Health
ABSTRACT INTRODUCTION: The availability of monoclonal antibodies in Cuba has
facilitated development and application of innovative techniques (immunoscintigraphy and …
facilitated development and application of innovative techniques (immunoscintigraphy and …
Antibody fragment and targeted colorectal cancer therapy: A global systematic review
Background and Aims: Antibody-based therapeutics have been shown to be promising for
the treatment of colorectal cancer patients. However, the size and long-circulating half-lives …
the treatment of colorectal cancer patients. However, the size and long-circulating half-lives …
[HTML][HTML] Radiofármacos en inmunocentelleografía y radioinmunoterapia
R Leyva Montaña, A Perera, JA Morín Zorrilla - Nucleus, 2012 - scielo.sld.cu
La alta morbilidad y letalidad del cáncer, hacen que esta enfermedad se considere, tanto en
Cuba como en el mundo, un serio problema de salud. La radioimmunodiagnosis y la …
Cuba como en el mundo, un serio problema de salud. La radioimmunodiagnosis y la …
[PDF][PDF] 含组氨酸标签的小分子抗体临床应用现状
刘晓， 屈琳， 黄昌发， 余馨， 罗勤 - 中国医药生物技术, 2012 - cmbp.net.cn
单链抗体(scFv) 是由免疫球蛋白的重链可变区(VH) 和轻链可变区(VL) 通过一条连接肽,
如(GGGGS) 4 连接而成的小分子抗体(图1). 与全抗相比, 它因分子小, 容易进入实体肿瘤 …
如(GGGGS) 4 连接而成的小分子抗体(图1). 与全抗相比, 它因分子小, 容易进入实体肿瘤 …